FDA Approves Medtronic’s Specify SureScan MRI Surgical Leads

The FDA has approved Medtronic’s Specify SureScan MRI surgical leads, as a part of the company’s full suite of implantable spinal cord stimulation systems for the treatment of chronic back and/or limb pain.

Medtronic currently is the only company that provides a complete portfolio of SCS systems that are FDA-cleared for full-body MRI, the device titan says.

The new leads will be available later this month. — Anisa Jibrell